A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy
Clinical trial NCT04352413 · TERMINATED
Trial details
- NCT number
- NCT04352413
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2022-01-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.